Trial Profile
Phase 2 proof of concept study of MBC-11
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Cytarabine/etidronic acid (Primary)
- Indications Bone metastases
- Focus Proof of concept; Therapeutic Use
- 06 Jun 2017 New trial record